The Age compiled a special edition of the Melbourne Magazine to honour the contributions and acheivements of Melbournians across 14 specialty fields. Amongst the “Top 100″ achievers in the field of Science and Health, was Fibrotech’s Director and CEO Associate Professor Darren Kelly. Kelly was commended on his leadership and involvement in the development of FT011. His team were acknowledged for their potential in developing “the worlds first anti-fibrotic drug”.